Skip to Main Content

Paper Details

p53 mutant-type in human prostate cancer cells determines the sensitivity to phenethyl isothiocyanate induced growth inhibition.
J Exp Clin Cancer Res
21
2019
ATM, DU145 cells, Ki67, LAPC, LAPC-4, Mice, PEITC, SK-BR-3, VCaP), breast xenograft model, cancer, cancer cell, cancer cell type, cancers, human, human prostate cancer cells, mutant cells, mutant p53, normal prostate cells, p53, p53 mutant, p53 mutants, p53 mutation, p53 mutations, p53 null, p53 protein, p53 targets, p53P223L, p53P223L mutant, p53P223L/V274F mutants, p53R175H, p53R175H mutant, p53R175H structural (LAPC-4) mutant cells, p53R248W, p53R248W contact, p53V274F, phenethyl isothiocyanate, prostate, prostate cancer, prostate cancer cell lines, prostate cancer cells, tumor, wild-type p53, xenograft tumor tissues
Author NameAffiliation
Elizabeth SinclairLombardi Comprehensive Cancer Center, Georgetown University
Deborah L BerryLombardi Comprehensive Cancer Center, Georgetown University
Bhaskar KallakuryLombardi Comprehensive Cancer Center, Georgetown University
  • 1 - 3

Datasets